Clinical Trials Directory

Trials / Completed

CompletedNCT01491568

rhBMP-2/CRM/CD HORIZON® Spinal System Pilot Study (2-Level)

Pilot Study of Recombinant Human Bone Morphogenetic Protein-2 and Compression Resistant Matrix With the CD HORIZON® Spinal System for Posterolateral Lumbar Fusion in Patients With Symptomatic DDD at Two Adjacent Vertebral Levels

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
29 (actual)
Sponsor
Medtronic Spinal and Biologics · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the feasibility of using the investigational implant (rhBMP-2/CRM with the CD HORIZON® Spinal System) as a method of facilitating posterolateral lumbar spinal fusion at two adjacent treatment levels in patients with symptomatic degenerative disc disease.

Conditions

Interventions

TypeNameDescription
DEVICErhBMP-2/CRM/CD HORIZON® Spinal SystemrhBMP-2/CRM with the CD HORIZON® SpinalSystem

Timeline

Start date
2005-07-01
Primary completion
2009-05-01
Completion
2010-11-01
First posted
2011-12-14
Last updated
2023-05-11

Source: ClinicalTrials.gov record NCT01491568. Inclusion in this directory is not an endorsement.

rhBMP-2/CRM/CD HORIZON® Spinal System Pilot Study (2-Level) (NCT01491568) · Clinical Trials Directory